TABACUM-INJEEL LIQ (12D,30D,200D/1.1ML) DIN 02065304
Health Canada record
| Active ingredient(s) | NICOTINE 12 D |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | HOMEOPATHIC |
| Class | Human |
| ATC | |
| Original market date | 31-Dec-1994 |
| Current status date | 10-Mar-1997 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing NICOTINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 01968106 | NICODERM TRD 114MG NICOTINE/21 | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | Patch | NICOTINE 114 MG | Cancelled Post Market |
| 01968122 | NICODERM TRD 36MG NICOTINE/7 SQCM PATCH | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | Patch | NICOTINE 36 MG | Cancelled Post Market |
| 01968114 | NICODERM TRD 78MG NICOTINE/14 | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | Patch | NICOTINE 78 MG | Cancelled Post Market |
| 00580317 | NICORETTE GUM 2MG | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | Gum | NICOTINE 2 MG | Cancelled Post Market |
| 02362066 | NICORETTE INVISIPATCH | MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | Patch | NICOTINE 25 MG | Cancelled Pre Market |
| 00580325 | NICORETTE PLUS 4MG | MERRELL DOW PHARMACEUTICALS (CANADA) INC., DIVISION OF MMDC | Gum | NICOTINE 4 MG | Cancelled Post Market |
| 02234630 | NICOTINUM | DOLISOS CANADA INC. | Granules; Globules; Liquid | NICOTINE 6 X | Cancelled Post Market |
International API supply for NICOTINE
6 valid EDQM Certificates of Suitability from 6 holders. 29 active FDA Drug Master Files.
Request a quote for TABACUM-INJEEL LIQ (12D,30D,200D/1.1ML)